Volume 10, Issue 2 (2025)
SJMR 2025, 10(2): 71-77 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Safari N, Shafti V, Azarboo A. Assessment of Awareness of Women Aged 18-35 Years about Polycystic Ovary Syndrome (PCOS) among Patients Visiting Hospitals Affiliated with Islamic Azad University, Tehran, in 2024. SJMR 2025; 10 (2) : 4
URL: http://saremjrm.com/article-1-367-en.html
URL: http://saremjrm.com/article-1-367-en.html
1- School of Medicine, Tehran Branch, Islamic Azad University, Tehran, Iran.
2- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (95 Views)
Background: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. It can lead to several complications such as infertility, type 2 diabetes, cardiovascular disease, and psychological issues. In most cases, late diagnosis leads to metabolic problems, such as obesity and insulin resistance, which affect their quality of life. Awareness of this syndrome plays a crucial role in prevention, early diagnosis, and effective management.
Objective: This study aimed to determine the level of awareness among women aged 18–35, referring to hospitals of Islamic Azad University in Tehran, regarding various aspects of PCOS including symptoms, complications, prevention methods, and treatments.
Materials and Methods: This descriptive cross-sectional study was conducted in 2024 on 138 women using convenience sampling. Data were collected via researcher-made questionnaires and interviews, and analyzed using Chi-square and independent t-tests.
Results: The mean age of participants was 27.3 ± 5.4 years. Overall awareness of PCOS was found in 30.4% of the women. Educational level, information source and occupational background had significant associations with some aspects of awareness (p < 0.05). Those with higher education or medical information sources had greater awareness.
Conclusion: The findings showed a low general awareness of PCOS. Demographic factors such as education and information source significantly influenced awareness levels. Thus, implementing targeted educational programs through reliable sources is essential.
Objective: This study aimed to determine the level of awareness among women aged 18–35, referring to hospitals of Islamic Azad University in Tehran, regarding various aspects of PCOS including symptoms, complications, prevention methods, and treatments.
Materials and Methods: This descriptive cross-sectional study was conducted in 2024 on 138 women using convenience sampling. Data were collected via researcher-made questionnaires and interviews, and analyzed using Chi-square and independent t-tests.
Results: The mean age of participants was 27.3 ± 5.4 years. Overall awareness of PCOS was found in 30.4% of the women. Educational level, information source and occupational background had significant associations with some aspects of awareness (p < 0.05). Those with higher education or medical information sources had greater awareness.
Conclusion: The findings showed a low general awareness of PCOS. Demographic factors such as education and information source significantly influenced awareness levels. Thus, implementing targeted educational programs through reliable sources is essential.
Article number: 4
Article Type: Original Research |
Subject:
Women Diseases
Received: 2025/07/19 | Accepted: 2025/08/3 | Published: 2025/08/13
Received: 2025/07/19 | Accepted: 2025/08/3 | Published: 2025/08/13
References
1. 1. Ghafari A, Maftoohi M, Samarin ME, Barani S, Banimohammad M, Samie R. The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment. Endocrine and Metabolic Science. 2025;17:100228. [DOI:10.1016/j.endmts.2025.100228]
2. Vidya Bharathi R, Swetha S, Neerajaa J, Varsha Madhavica J, Janani DM, Rekha SN, et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertility Society Journal. 2017;22(4):313-6. [DOI:10.1016/j.mefs.2017.05.007]
3. Zaitoun B, Al Kubaisi A, AlQattan N, Alassouli Y, Mohammad A, Alameeri H, et al. Polycystic ovarian syndrome awareness among females in the UAE: a cross-sectional study. BMC Womens Health. 2023;23(1):181. [DOI:10.1186/s12905-023-02318-y] [PMID] []
4. Bohsas H, Alibrahim H, Swed S, Abouainain Y, Aljabali A, Kazan L, et al. Prevalence and knowledge of polycystic ovary syndrome (PCOS) and health-related practices among women of Syria: a cross-sectional study. J Psychosom Obstet Gynaecol. 2024;45(1):2318194. [DOI:10.1080/0167482X.2024.2318194] [PMID]
5. Crespo RP, Bachega T, Mendonça BB, Gomes LG. An update of genetic basis of PCOS pathogenesis. Arch Endocrinol Metab. 2018;62(3):352-61. [DOI:10.20945/2359-3997000000049] [PMID] []
6. Puttabyatappa M, Padmanabhan V. Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome. J Mol Endocrinol. 2018;61(4):R161-r84. [DOI:10.1530/JME-18-0079] [PMID] []
7. Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020;13(4):261-71. [DOI:10.4103/jhrs.JHRS_95_18] [PMID] []
8. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1-13. [DOI:10.2147/CLEP.S37559] [PMID] []
9. Hallajzadeh J, Khoramdad M, Karamzad N, Almasi-Hashiani A, Janati A, Ayubi E, et al. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res. 2018;10(2):56-69. [DOI:10.15171/jcvtr.2018.10] [PMID] []
10. van Keizerswaard J, Dietz de Loos ALP, Louwers YV, Laven JSE. Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study. Fertil Steril. 2022;117(5):1059-66. [DOI:10.1016/j.fertnstert.2022.01.014] [PMID]
11. Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230-44. [DOI:10.1038/s41574-024-01057-w] [PMID]
12. Hayes E, Winston N, Stocco C. Molecular crosstalk between insulin-like growth factors and follicle-stimulating hormone in the regulation of granulosa cell function. Reprod Med Biol. 2024;23(1):e12575. [DOI:10.1002/rmb2.12575] [PMID] []
13. Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619-31. [DOI:10.1093/humrep/dew243] [PMID]
14. Carvalho LML, Dos Reis FM, Candido AL, Nunes FFC, Ferreira CN, Gomes KB. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review. Endocr Regul. 2018;52(4):208-21. [DOI:10.2478/enr-2018-0026] [PMID]
15. Marciniak A, Lejman-Larysz K, Nawrocka-Rutkowska J, Brodowska A, Songin D. [Polycystic ovary syndrome - current state of knowledge]. Pol Merkur Lekarski. 2018;44(264):296-301.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
